Showing results (71-80 of 108) with videos related to
Sort By:
Pageof 11
Molecular and Cellular Biology|May 11, 2000
Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNAH Niida, Y Shinkai, M P Hande, et al.Scientific Reports|March 31, 2022
NU-9 improves health of hSOD1<sup>G93A</sup> mouse upper motor neurons in vitro, especially in combination with riluzole or edaravoneBarış Genç, Mukesh Gautam, Benjamin R Helmold, et al.Environmental Health Perspectives|May 1, 1996
Current cytogenetic methods for detecting exposure and effects of mutagens and carcinogensA T Natarajan, J J Boei, F Darroudi, et al.Journal of Gastrointestinal Oncology|March 21, 2025
New onset diabetes predicts clinical outcomes in patients with pancreatic adenocarcinomaChirayu Mohindroo, Paul S Dy, Suraj P Hande, et al.Current Biology : CB|August 23, 2001
Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cellsF d'Adda di Fagagna, M P Hande, W M Tong, et al.Gene Therapy|December 2, 2021
Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neuronsBarış Genç, Javier H Jara, Santana S Sanchez, et al.Mutagenesis|December 26, 2001
Chromosomal rearrangements involving telomeric DNA sequences in Balb/3T3 cells transfected with the Ha-ras oncogenePaulo Peitl, Stephano S Mello, Marjori L Camparoto, et al.Cerebral Cortex (New York, N.Y. : 1991)|January 18, 2015
Corticospinal Motor Neurons Are Susceptible to Increased ER Stress and Display Profound Degeneration in the Absence of UCHL1 FunctionJavier H Jara, Barış Genç, Gregory A Cox, et al.Metabolites|February 25, 2022
2-Year-Old and 3-Year-Old Italian ALS Patients with Novel <i>ALS2</i> Mutations: Identification of Key Metabolites in Their Serum and PlasmaMukesh Gautam, Renata Del Carratore, Benjamin Helmold, et al.International Journal of Radiation Biology|January 31, 2003
Routine screening mammography: how important is the radiation-risk side of the benefit-risk equation?D J Brenner, S G Sawant, M P Hande, et al.Pageof 11